Texas Oncology - Presbyterian Dallas Cancer Center is a clinical research site located in Dallas, Texas, United States 75231.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Texas Oncology - Presbyterian Dallas Cancer Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Sponsors: Karyopharm Therapeutics Inc.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - Presbyterian Dallas Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - Presbyterian Dallas Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Texas Oncology - Presbyterian Dallas Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.